Products

Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
anti-MKK3 antibody, phosphorylated, 50 µg  

anti-MKK3 antibody, phosphorylated, 50 µg

rabbit polyclonal antibody anti-MKK3, phosphorylated (pSer189)

More details

AB-pMKK3-050

Availability: within 3 days

210,00 €

Product Description:  affinity purified rabbit polyclonal antibody anti-MKK3, phosphorylated (Ser189)
Antigen: MKK3 peptide sequence around phosphorylation site Ser189 (187)VDSVA(191)
Species Reactivity: for MKK3 (human, rat)
Host: rabbit
Background: MEK3 / MKK3 is a dual specificity kinase belonging to the group of MAP kinase kinase (MKKs). MKKs are one part of three-kinase phosphorelay system „MAPK cascade“ that converts extra cellular stimuli into various cellular responses such as gene expression, mitosis, and differentiation, proliferation, and cell survival/apoptosis. Upon phosphorylation by MKKKs (e.g. MLKs, ASK1, TAK1) activated MEK3 / MKK3 is able to phosphorylate the Thr - Gly -Tyr motif in the activation loop of p38α, p38β, p38γ and p38δ. MKK6, a closely related MKK serves also as activator of p38 MAPK. The activation of the  p38MAPKs by one or more MKK is stimulus-specific and cell specific. Whereas MKK3 seems to be the major activator of p38 in mesangial cells, MKK6 appears to be the predominant isoform in thymocytes. In contrast, both kinases are needed for full p38α activation in response to stimulation by TNFα. Upon UV irradiation, p38α is activated by MKK3, MKK6 and MKK4, which has also a minor contribution for p38α activity.

Formulation:  Supplied at 1.0 mg/ml in phosphate buffered saline pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol
Applications: Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Working Dilutions: Antibody dilutions should be based on tissue type and expression level. 

WB: 1:500~1:1000
IHC: 1:50 ~ 1:100
IF: 1:100 ~ 1:200

Storage and Stability:  Store at -20°C / one year.

Product specific literature:

Remy G, Risco AM, Iñesta-Vaquera FA, González-Terán B, Sabio G, Davis RJ, Cuenda A. (2010) “Differential activation of p38MAPK isoforms by MKK6 and MKK3.” Cell Signal. 22(4):660-7.

Cuenda A, Rousseau S. (2007) „ p38 MAP-kinases pathway regulation, function and role in human diseases.“ Biochim Biophys Acta, 1773(8):1358-75.

N. Tanaka, M. Kamanaka, H. Enslen, C. Dong, M.Wysk, R.J. Davis, R.A.Flavell,(2002) “Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis” EMBO Rep. 3 785–791.

L. Wang, R. Ma, R.A. Flavell, M.E. Choi,(2002) “Requirement of mitogenactivated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cell” J. Biol. Chem. 277 47257–47262.